SEC Form 3 · accession 0001209191-18-050892

Principia Biopharma Inc. · PRNB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Senior VP of Strategy and Ops

Period of report

Sep 13, 2018

Accepted (ET)

Sep 13, 2018 · 5:07 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001510487

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	holding	—	—		—	32,668	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F1	$4.542	holding	—	—	—	—	Feb 15, 2027	Common Stock	30,055	—	D
Employee Stock Option (right to buy)^F2	$7.2671	holding	—	—	—	—	Dec 13, 2027	Common Stock	16,843	—	D
Employee Stock Option (right to buy)^F3	$11.3549	holding	—	—	—	—	Aug 23, 2028	Common Stock	22,017	—	D
Employee Stock Option (right to buy)^F3	$17.00	holding	—	—	—	—	Aug 27, 2028	Common Stock	55,024	—	D

F1The stock option vested and became exercisable as to 25% of the shares subject to the option on July 1, 2017, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
F2The stock option will vest and become exercisable as to 25% of the shares subject to the option on December 14, 2018, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
F3The stock option will vest and become exercisable as to 25% of the shares subject to the option on August 23, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.